ORKA
Oruka Therapeutics, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.13B
P/E Ratio
—
EPS
$-1.93
Beta
—
52W High
$91.00
52W Low
$10.77
50-Day MA
$63.31
200-Day MA
$37.33
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. is a biotechnology company.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-133.29M |
| Operating Margin | 0.00% |
| Return on Equity | -27.30% |
| Return on Assets | -18.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $9.64 |
| Price-to-Book | 8.54 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $60.31M |
| Float | $51.05M |
| % Insiders | 1.29% |
| % Institutions | 88.55% |
Historical Volatility
HV 10-Day
80.59%
HV 20-Day
69.87%
HV 30-Day
71.49%
HV 60-Day
73.58%
HV Rank
62.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($142.17 target)
2
Strong Buy11
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026